Elsevier

Neuroscience

Volume 73, Issue 1, July 1996, Pages 79-84
Neuroscience

Choline acetyltransferase activity and vesamicol binding in Rett syndrome and in rats with nucleus basalis lesions

https://doi.org/10.1016/0306-4522(96)00019-XGet rights and content

Abstract

The decline in choline acetyltransferase activity has been identified previously within the brains of patients with Rett syndrome and Alzheimer's disease. The level of [3H]vesamicol binding to a terminal vesicular acetylcholine transporter is inversely related to the decline in cortical choline acetyltransferase activity in Alzheimer's disease, which may be due to compensatory processes within surviving cholinergic terminals. In order to investigate whether similar cholinergic compensatory processes are present in the Rett syndrome brain and are altered by normal aging, we investigated the density of cholinergic vesicular transporters in (i) the brains of Rett syndrome patients, and (ii) young and old rats with experimentally-induced cholinergic cell loss. In Rett syndrome, a significant decline in choline acetyltransferase activity within the putamen and thalamus was directly correlated with a decline in [3H]vesamicol binding. In both young and old rats, basal forebrain lesions decreased cortical choline acetyltransferase activity significantly, while [3H]vesamicol binding was unchanged.

In contrast to young and old lesioned rats and patients with Alzheimer's disease, cholinergic cells in the brains of patients with Rett syndrome do not compensate for the loss of cholinergic cells by increasing acetylcholine vesicular storage.

References (38)

  • RyeD.B. et al.

    Cortical projections arising from the basal forebrain: a study of cholinergic and noncholinergic components employing combined retrograde tracing and immunohistochemical localization of choline acetyltransferase

    Neuroscience

    (1984)
  • VaroquiH. et al.

    Cloning and expression of the vesamicol binding protein from the marine ray Torpedo: homology with the putative vesicular acetylcholine transporter UNC-17 from Caenorhabditis elegans

    Fedn Eur. biochem. Socs

    (1994)
  • WenkG.L. et al.

    Neurochemical alterations in Rett syndrome

    Devl Brain Res.

    (1993)
  • WenkG.L. et al.

    Age-related decrease in vulnerability to excitatory amino acids in the nucleus basalis

    Neurobiol. Aging

    (1996)
  • AlfonsoA. et al.

    The Caenorhabditis elegans unc-17 gene: a putative vesicular acetylcholine transporter

    Science

    (1993)
  • AltarC.A. et al.

    [3H]Vesamicol binding in brain: autoradiographic distribution, pharmacology, and effects of cholinergic lesions

    Synapse

    (1988)
  • BahrB.A. et al.

    Purification of the vesamicol receptor

    Biochemistry

    (1992)
  • BelichenkoP.V. et al.

    Rett syndrome: 3-D confocal microscopy of cortical pyramidal dendrites and afferents

    Neuroreport

    (1994)
  • BronzettiE. et al.

    Muscarinic cholinoceptor subtypes in the rat frontoparietal cortex after ipsilateral lesions of the nucleus basalis magnocellularis

    Pharmacology

    (1993)
  • Cited by (42)

    • Mouse models of neurodevelopmental disease of the basal ganglia and associated circuits

      2014, Current Topics in Developmental Biology
      Citation Excerpt :

      These results suggest a degree of specificity in affected dopaminergic systems. There is also evidence for striatal cholinergic dysfunction in RTT (Wenk & Mobley, 1996). For example, striatal vesicular acetylcholine transporter densities are reduced in women with RTT, and their clinical abilities are correlated with these levels (Brasic et al., 2012).

    • Rett syndrome: From bed to bench

      2011, Pediatrics and Neonatology
      Citation Excerpt :

      Nevertheless, cerebrospinal fluid and brain tissues have been analyzed with respect to levels of various transmitters, receptors, and additional trophic factors. Abnormalities have been reported in most systems, including in acetylcholine,46–48 dopamine,49–53 serotonin,54,55 glutamate,56,57 substance P,58,59 and nerve growth factor.60,61 The age of the patient with RTT52 and the severity of the symptoms53 influence measurements.

    • Nutritional factors in a mouse model of Rett syndrome

      2009, Neuroscience and Biobehavioral Reviews
    View all citing articles on Scopus
    View full text